GT200800102A - Compuestos y metodos para inhibir la interaccion de proteinas bcl con moleculas de enlace - Google Patents

Compuestos y metodos para inhibir la interaccion de proteinas bcl con moleculas de enlace

Info

Publication number
GT200800102A
GT200800102A GT200800102A GT200800102A GT200800102A GT 200800102 A GT200800102 A GT 200800102A GT 200800102 A GT200800102 A GT 200800102A GT 200800102 A GT200800102 A GT 200800102A GT 200800102 A GT200800102 A GT 200800102A
Authority
GT
Guatemala
Prior art keywords
inhibit
compounds
interaction
methods
bcl proteins
Prior art date
Application number
GT200800102A
Other languages
English (en)
Inventor
Alfredo C Castro
Michael J Grogan
Edward B Holson
Brian T Hopkins
Nii O Koney
Peluso Stephane
Daniel A Snyder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800102A publication Critical patent/GT200800102A/es

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01SDEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/05Construction or shape of optical resonators; Accommodation of active medium therein; Shape of active medium
    • H01S3/06Construction or shape of active medium
    • H01S3/063Waveguide lasers, i.e. whereby the dimensions of the waveguide are of the order of the light wavelength
    • H01S3/067Fibre lasers
    • H01S3/06754Fibre amplifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/02Optical fibres with cladding with or without a coating
    • G02B6/02004Optical fibres with cladding with or without a coating characterised by the core effective area or mode field radius
    • G02B6/02009Large effective area or mode field radius, e.g. to reduce nonlinear effects in single mode fibres
    • G02B6/02014Effective area greater than 60 square microns in the C band, i.e. 1530-1565 nm
    • G02B6/02019Effective area greater than 90 square microns in the C band, i.e. 1530-1565 nm
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/02Optical fibres with cladding with or without a coating
    • G02B6/036Optical fibres with cladding with or without a coating core or cladding comprising multiple layers
    • G02B6/03605Highest refractive index not on central axis
    • G02B6/03611Highest index adjacent to central axis region, e.g. annular core, coaxial ring, centreline depression affecting waveguiding
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/10Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings of the optical waveguide type
    • G02B6/14Mode converters
    • GPHYSICS
    • G02OPTICS
    • G02BOPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B6/00Light guides; Structural details of arrangements comprising light guides and other optical elements, e.g. couplings
    • G02B6/24Coupling light guides
    • G02B6/26Optical coupling means
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01SDEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/05Construction or shape of optical resonators; Accommodation of active medium therein; Shape of active medium
    • H01S3/06Construction or shape of active medium
    • H01S3/063Waveguide lasers, i.e. whereby the dimensions of the waveguide are of the order of the light wavelength
    • H01S3/067Fibre lasers
    • H01S3/06708Constructional details of the fibre, e.g. compositions, cross-section, shape or tapering
    • H01S3/0672Non-uniform radial doping
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01SDEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/05Construction or shape of optical resonators; Accommodation of active medium therein; Shape of active medium
    • H01S3/06Construction or shape of active medium
    • H01S3/063Waveguide lasers, i.e. whereby the dimensions of the waveguide are of the order of the light wavelength
    • H01S3/067Fibre lasers
    • H01S3/06708Constructional details of the fibre, e.g. compositions, cross-section, shape or tapering
    • H01S3/06729Peculiar transverse fibre profile
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01SDEVICES USING THE PROCESS OF LIGHT AMPLIFICATION BY STIMULATED EMISSION OF RADIATION [LASER] TO AMPLIFY OR GENERATE LIGHT; DEVICES USING STIMULATED EMISSION OF ELECTROMAGNETIC RADIATION IN WAVE RANGES OTHER THAN OPTICAL
    • H01S3/00Lasers, i.e. devices using stimulated emission of electromagnetic radiation in the infrared, visible or ultraviolet wave range
    • H01S3/05Construction or shape of optical resonators; Accommodation of active medium therein; Shape of active medium
    • H01S3/06Construction or shape of active medium
    • H01S3/063Waveguide lasers, i.e. whereby the dimensions of the waveguide are of the order of the light wavelength
    • H01S3/067Fibre lasers
    • H01S3/06708Constructional details of the fibre, e.g. compositions, cross-section, shape or tapering
    • H01S3/06745Tapering of the fibre, core or active region

Landscapes

  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plasma & Fusion (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Lasers (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL PRESENTE INVENTO SE RELACIONA CON LOS COMPUESTOS HETEROCÍCLICOS QUE ENLAZAN PROTEÍNAS BCL E INHIBE LA FUNCIÓN DE LAS PROTEÍNAS BCL. EN OTRO ASPECTO DEL PRESENTE INVENTO SE RELACIONA CON LAS COMPOSICIONES QUE CONTIENEN COMPUESTOS HETEROCÍCLICOS DEL INVENTO. EL PRESENTE INVENTO TAMBIÉN PROPORCIONA LOS MÉTODOS PARA EL TRATAMIENTO Y MODULACIÓN DE LOS DESÓRDENES RELACIONADOS CON LA HOPERPROLIFERACIÓN, TAL COMO EL CÁNCER. T2008
GT200800102A 2005-12-16 2008-06-13 Compuestos y metodos para inhibir la interaccion de proteinas bcl con moleculas de enlace GT200800102A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75096705P 2005-12-16 2005-12-16

Publications (1)

Publication Number Publication Date
GT200800102A true GT200800102A (es) 2009-03-18

Family

ID=38120169

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800102A GT200800102A (es) 2005-12-16 2008-06-13 Compuestos y metodos para inhibir la interaccion de proteinas bcl con moleculas de enlace

Country Status (4)

Country Link
EP (1) EP1811616B1 (es)
JP (1) JP4959314B2 (es)
CN (1) CN1982929B (es)
GT (1) GT200800102A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070140634A1 (en) * 2005-12-16 2007-06-21 Robert Scott Windeler Gain-producing, large-mode-area, multimode, hybrid optical fibers and devices using same
US7356232B1 (en) * 2006-08-01 2008-04-08 Furukawa Electric North America Optical fibers for high power applications
JP5254077B2 (ja) * 2009-02-25 2013-08-07 国立大学法人 千葉大学 光渦発生装置と方法
US8068705B2 (en) * 2009-09-14 2011-11-29 Gapontsev Valentin P Single-mode high-power fiber laser system
CN101891380B (zh) 2010-07-13 2012-07-04 长飞光纤光缆有限公司 一种大尺寸光纤预制棒及其光纤的制造方法
US10761267B2 (en) * 2015-08-13 2020-09-01 Nufem Mode mixing optical fibers and methods and systems using the same
CN109642981B (zh) * 2016-02-05 2021-07-27 纽弗恩 模式混合光纤以及使用其的方法和系统
CN109031516B (zh) * 2018-07-11 2020-12-29 烽火通信科技股份有限公司 一种大模场双包层掺镱光纤
FR3108412B1 (fr) * 2020-03-23 2022-02-18 Compagnie Ind Des Lasers Cilas Guide d’onde multimode configuré pour générer une radiation monomode à partir d’une radiation monomode.
WO2023195280A1 (ja) * 2022-04-07 2023-10-12 ソニーグループ株式会社 光ケーブル、電子機器および光通信システム

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9814526D0 (en) * 1998-07-03 1998-09-02 Univ Southampton Optical fibre and optical fibre device
US6324326B1 (en) * 1999-08-20 2001-11-27 Corning Incorporated Tapered fiber laser
AU2002220816A1 (en) * 2000-11-09 2002-05-21 Nortel Networks Limited Optical amplifier method and apparatus
US20020168139A1 (en) * 2001-03-30 2002-11-14 Clarkson William Andrew Optical fiber terminations, optical couplers and optical coupling methods
US6563995B2 (en) * 2001-04-02 2003-05-13 Lightwave Electronics Optical wavelength filtering apparatus with depressed-index claddings
EP1488548A4 (en) * 2002-03-08 2009-11-11 Lightwave Electronics COMMUNICATION SYSTEM AND RIBBED SPREADING DEVICE WITH A FIBER AMPLIFIER WITH A PRESSED PROFILE
JP2004063931A (ja) * 2002-07-31 2004-02-26 Kyocera Corp 光増幅ファイバ
JP2006527494A (ja) * 2003-06-12 2006-11-30 エスピーアイ レーザーズ ユーケー リミテッド 輝度コンバータを有する光放射を提供する光学装置
US6970624B2 (en) * 2003-06-13 2005-11-29 Furukawa Electric North America Cladding pumped optical fiber gain devices
US7436583B2 (en) * 2003-09-05 2008-10-14 Sumitomo Electric Industries, Ltd. Optical amplification fiber, optical amplifier module, optical communication system and optical amplifying method
ATE445244T1 (de) * 2003-10-24 2009-10-15 Koheras As Optisches system zur bereitstellung von kurzen laserimpulsen
US7062139B2 (en) * 2003-12-03 2006-06-13 Prime Optical Fiber Corporation Core of an optical patch cord and an optical signal transmission system using the same and a method for preparing the same
EP1708971B1 (en) * 2004-01-20 2015-06-10 Corning Incorporated Double clad optical fiber with rare earth metal doped glass core
US20070140634A1 (en) * 2005-12-16 2007-06-21 Robert Scott Windeler Gain-producing, large-mode-area, multimode, hybrid optical fibers and devices using same

Also Published As

Publication number Publication date
CN1982929B (zh) 2011-01-26
EP1811616A2 (en) 2007-07-25
JP4959314B2 (ja) 2012-06-20
JP2007165906A (ja) 2007-06-28
EP1811616A3 (en) 2011-09-07
CN1982929A (zh) 2007-06-20
EP1811616B1 (en) 2017-01-04

Similar Documents

Publication Publication Date Title
GT200800102A (es) Compuestos y metodos para inhibir la interaccion de proteinas bcl con moleculas de enlace
GT200900123A (es) Compuestos y metodos para inhibir la interacción de las proteinas bcl con molécula de enlace
CR9225A (es) Derivados del pirimidinil y piridinil sustituidos como moduladores del metabolismo y el tratamiento de desordenes relacionados con el mismo
PA8719401A1 (es) Compuestos de tetrahidropiridotienopirimidina y metodos para su empleo
CY1121299T1 (el) Υποκατεστημενες τρικυκλικες ενωσεις ως αναστολεις fgfr
PA8842101A1 (es) Heteroarilos sustituidos
GT200900146A (es) Inhibidores de la actividad de la akt
UY29414A1 (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos
ECSP11010798A (es) 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa
CY1109985T1 (el) Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
ECSP077836A (es) Compuestos mejorados farmacocinéticamente
GT200500237A (es) Derivados de pirimidina
BRPI0808775A2 (pt) compostos e composições como moduladores de atividade de gpr119
UY35472A (es) Compuestos y sus usos en la modulacion de la hemoglobina
CL2008002793A1 (es) Compuestos derivados de amidas sustituidas, inhibidores de la actividad de btk; composicion farmaceutica que los comprende; utiles en el tratamiento del cancer, trastornos oseos, enfermedades autoinmunes, entre otras
EA201101521A1 (ru) Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
CR20120510A (es) Derivados de piperidin-4-il azetidina como inhibidores de jak1
ECSP088440A (es) Imidazopirazinas como inhibidores de proteinquinasa
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
SV2010003556A (es) Moleculas y metodos para modular el componente de complemento
UY31432A1 (es) Compuestos de diarilhidantoina
MA32508B1 (fr) Composes organiques
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
UY32359A (es) Compuestos de plasmalogenos, composiciones farmaceuticas que los contienen y metodos para tratar enfermedades del envejecimiento